Showcase: Avast Therapeutics

April 20, 2026 9:45–10:03 AM
Broadway 3
Sectors
Session Type

Avast Therapeutics is developing first-in-class, non-invasive peptide therapeutics that safely cross the blood-brain barrier to restore mitochondrial function and protect neurons.

This breakthrough approach targets neurodegenerative diseases such as Parkinson’s and Alzheimer’s at their earliest stages, with the potential to halt disease progression and transform brain medicine.

Showcase: Annoviant, Inc.

April 20, 2026 9:25–9:43 AM
Broadway 3
Sectors
Session Type

Annoviant is advancing patient outcomes in heart disease by delivering innovative, regenerative cardiovascular devices built on its proprietary TxGuard™ soft-tissue technology.

The platform enables durable, off-the-shelf solutions that address critical unmet needs in heart valve disease and coronary artery bypass grafting—helping patients live healthier lives while reducing long-term healthcare costs.

Regional VC Panel Session: How Regional Funds are Rewriting the Southeast Startup Story

April 20, 2026 8:10–9:00 AM
Broadway 1-2
Session Type
Regional VC Panel Session
Holland & Knight

Join leading venture capitalists as they discuss the evolving startup landscape in the Southeast. Learn how regional funds are driving innovation, supporting emerging companies, and reshaping the path to growth for local startups.